gip and glp 1 receptor agonist Understand GLP-1/GIP Dual Tirzepatide Its Effect on Current Weight Loss Therapy The Effects of Dual GLP-1/GIP
Description
Five to ten percent of patients discontinued the drug across doses, the company said, which was one of two late-stage trials the drug must pass before being submitted for federal approval
Both are normal
This pricing dynamic constrains overall market penetration and slows adoption despite the strong clinical benefits of GLP-1 therapies in weight management and glycemic control, making cost a key obstacle to broader global uptake
N., Wharton, S., Connery, L., Alves, B., et al
379: 6972 [DOI] [PubMed] [Google Scholar] 154.Kinzig KP, DAlessio DA, Seeley RJ
JAMA 316 , 500508 (2016)
